Belal Azab

2.5k total citations
62 papers, 1.8k citations indexed

About

Belal Azab is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Belal Azab has authored 62 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 17 papers in Genetics and 14 papers in Oncology. Recurrent topics in Belal Azab's work include Virus-based gene therapy research (11 papers), RNA Interference and Gene Delivery (6 papers) and CAR-T cell therapy research (6 papers). Belal Azab is often cited by papers focused on Virus-based gene therapy research (11 papers), RNA Interference and Gene Delivery (6 papers) and CAR-T cell therapy research (6 papers). Belal Azab collaborates with scholars based in United States, Jordan and South Korea. Belal Azab's co-authors include Devanand Sarkar, Paul B. Fisher, Swadesh K. Das, Rupesh Dash, Sujit K. Bhutia, Zhao-zhong Su, Seok‐Geun Lee, David T. Curiel, Tareq Saleh and B. N. Prashanth Kumar and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Biomaterials.

In The Last Decade

Belal Azab

57 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Belal Azab United States 22 914 523 322 279 229 62 1.8k
Bret M. Evers United States 23 963 1.1× 475 0.9× 237 0.7× 253 0.9× 198 0.9× 89 2.0k
Chia‐Ling Hsieh Taiwan 31 1.4k 1.5× 659 1.3× 350 1.1× 355 1.3× 484 2.1× 86 2.5k
Yang Jiang China 29 1.3k 1.4× 291 0.6× 117 0.4× 455 1.6× 325 1.4× 84 2.4k
Fengqin Gao United States 25 1.6k 1.7× 511 1.0× 109 0.3× 172 0.6× 268 1.2× 66 2.2k
Xiaochun Peng China 23 807 0.9× 490 0.9× 132 0.4× 321 1.2× 226 1.0× 74 1.8k
Laurent Martiny France 31 1.2k 1.3× 365 0.7× 453 1.4× 528 1.9× 657 2.9× 94 2.6k
Chundong Yu China 30 2.1k 2.3× 614 1.2× 346 1.1× 269 1.0× 479 2.1× 83 3.0k
Yi Lü United States 23 933 1.0× 349 0.7× 305 0.9× 154 0.6× 260 1.1× 68 1.6k
Tae‐Hyoung Kim South Korea 17 1.3k 1.5× 253 0.5× 128 0.4× 391 1.4× 347 1.5× 35 1.9k

Countries citing papers authored by Belal Azab

Since Specialization
Citations

This map shows the geographic impact of Belal Azab's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Belal Azab with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Belal Azab more than expected).

Fields of papers citing papers by Belal Azab

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Belal Azab. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Belal Azab. The network helps show where Belal Azab may publish in the future.

Co-authorship network of co-authors of Belal Azab

This figure shows the co-authorship network connecting the top 25 collaborators of Belal Azab. A scholar is included among the top collaborators of Belal Azab based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Belal Azab. Belal Azab is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ahmad, Fareed, et al.. (2025). Genetic profiling of Wilson disease reveals a potential recurrent pathogenic variant of ATP7B in the Jordanian population. Journal of Pediatric Gastroenterology and Nutrition. 80(3). 471–481.
2.
Shahin, Nisreen Abu, Mohammad A. Ismail, Nidaa A. Ababneh, et al.. (2023). A three-marker signature identifies senescence in human breast cancer exposed to neoadjuvant chemotherapy. Cancer Chemotherapy and Pharmacology. 91(4). 345–360. 17 indexed citations
3.
4.
Azab, Belal, et al.. (2022). Investigating the genetic profile of familial atypical cystic fibrosis patients (DeltaF508-CFTR) with neonatal biliary atresia. Journal of Applied Genetics. 64(1). 71–80. 1 indexed citations
5.
Al‐Iede, Montaha, et al.. (2021). A homozygous variant in ABCA3 is associated with severe respiratory distress and early neonatal death. Congenital Anomalies. 61(6). 231–233. 1 indexed citations
6.
7.
Tarboush, Nafez Abu, et al.. (2018). PKM2 and HIF-1α regulation in prostate cancer cell lines. PLoS ONE. 13(9). e0203745–e0203745. 39 indexed citations
8.
Azab, Belal, Mohammad Alsalem, Zaid Kilani, et al.. (2017). Novel frameshift variant in the IDUA gene underlies Mucopolysaccharidoses type I in a consanguineous Yemeni pedigree. Molecular Genetics and Metabolism Reports. 12. 76–79. 3 indexed citations
9.
Rajput, Shashi, B. N. Prashanth Kumar, Siddik Sarkar, et al.. (2013). Targeted Apoptotic Effects of Thymoquinone and Tamoxifen on XIAP Mediated Akt Regulation in Breast Cancer. PLoS ONE. 8(4). e61342–e61342. 104 indexed citations
10.
Sarkar, Siddik, Belal Azab, Swadesh K. Das, et al.. (2013). Chemoprevention Gene Therapy (CGT): Novel Combinatorial Approach for Preventing and Treating Pancreatic Cancer. Current Molecular Medicine. 13(7). 1140–1159. 8 indexed citations
11.
Das, Swadesh K., Sujit K. Bhutia, Upneet K. Sokhi, et al.. (2012). Raf Kinase Inhibitor RKIP Inhibits MDA-9/Syntenin-Mediated Metastasis in Melanoma. Cancer Research. 72(23). 6217–6226. 49 indexed citations
12.
Das, Swadesh K., Sujit K. Bhutia, Belal Azab, et al.. (2012). MDA-9/Syntenin and IGFBP-2 Promote Angiogenesis in Human Melanoma. Cancer Research. 73(2). 844–854. 79 indexed citations
13.
Dash, Rupesh, Belal Azab, Bridget A. Quinn, et al.. (2011). Apogossypol derivative BI-97C1 (Sabutoclax) targeting Mcl-1 sensitizes prostate cancer cells to mda -7/IL-24–mediated toxicity. Proceedings of the National Academy of Sciences. 108(21). 8785–8790. 101 indexed citations
14.
Venkatesan, P., Nagaprasad Puvvada, Rupesh Dash, et al.. (2011). The potential of celecoxib-loaded hydroxyapatite-chitosan nanocomposite for the treatment of colon cancer. Biomaterials. 32(15). 3794–3806. 215 indexed citations
15.
Bhutia, Sujit K., Rupesh Dash, Swadesh K. Das, et al.. (2010). Mechanism of Autophagy to Apoptosis Switch Triggered in Prostate Cancer Cells by Antitumor Cytokine Melanoma Differentiation-Associated Gene 7/Interleukin-24. Cancer Research. 70(9). 3667–3676. 102 indexed citations
16.
Dash, Rupesh, Joanna E. Richards, Zhao-zhong Su, et al.. (2010). Mechanism by Which Mcl-1 Regulates Cancer-Specific Apoptosis Triggered by mda-7/IL-24, an IL-10–Related Cytokine. Cancer Research. 70(12). 5034–5045. 65 indexed citations
17.
Das, Swadesh K., Sujit K. Bhutia, Upneet K. Sokhi, et al.. (2010). Human polynucleotide phosphorylase (hPNPaseold-35): an evolutionary conserved gene with an expanding repertoire of RNA degradation functions. Oncogene. 30(15). 1733–1743. 19 indexed citations
18.
Dash, Rupesh, Igor P. Dmitriev, Sujit K. Bhutia, et al.. (2010). Enhanced delivery of mda-7/IL-24 using a serotype chimeric adenovirus (Ad.5/3) improves therapeutic efficacy in low CAR prostate cancer cells. Cancer Gene Therapy. 17(7). 447–456. 42 indexed citations
19.
Dash, Rupesh, Sujit K. Bhutia, Belal Azab, et al.. (2010). mda-7/IL-24: A unique member of the IL-10 gene family promoting cancer-targeted toxicity. Cytokine & Growth Factor Reviews. 21(5). 381–391. 91 indexed citations
20.
Dash, Rupesh, Seok‐Geun Lee, Belal Azab, et al.. (2010). Inhibition of AP-1 by SARI negatively regulates transformation progression mediated by CCN1. Oncogene. 29(31). 4412–4423. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bret M. Evers Breakdown of academic impact, for papers by Chia‐Ling Hsieh Breakdown of academic impact, for papers by Yang Jiang Breakdown of academic impact, for papers by Fengqin Gao Breakdown of academic impact, for papers by Xiaochun Peng Breakdown of academic impact, for papers by Laurent Martiny Breakdown of academic impact, for papers by Chundong Yu Breakdown of academic impact, for papers by Yi Lü Breakdown of academic impact, for papers by Tae‐Hyoung Kim
Rankless by CCL
2026